EP Special Opportunities dives on Luceco profit warning – EP Special Opportunities’ shares are 23.3% lower at lunchtime today (15 December) following a profit warning from its largest investment. Luceco profit warning Luceco made the following announcement this morning “Luceco plc, the manufacturer and distributor of high quality and innovative LED lighting products, wiring accessories […]
Geiger Counter benefits from uranium production cuts – Geiger Counter says that, for the year to 30th September 2017 its net asset value fell by 7.3 per cent which was in line with the fall in the spot uranium price. The share price rose by 15.9 per cent over the year with the discount being 3.3 per […]
F&C Commercial Property buys Bristol office – F&C Commercial Property Holdings Limited, a subsidiary of F&C Commercial Property, has purchased a 56,059 sq ft prime office, One Cathedral Square, in Bristol for GBP33.5 million, reflecting a net initial yield of 5.0 per cent. The property is fully let to the strong covenants of the University of […]
Finsbury Growth outperforms again – Finsbury Growth & Income Trust’s net asset value return per share for the year was 13.7% (2016: 20.6%) and the share price total return was 14.2% (2016: 20.8%). Both outperformed the benchmark, the All-Share Index, measured on a total return basis, which rose by 11.9%. The total dividend for the year […]
Primary Healthcare Properties investing in Cork – Primary Health Properties ICAV, an Irish investment vehicle wholly owned by Primary Healthcare Properties, has agreed to acquire a large modern primary heathcare facility in County Cork, Ireland for a total cost of €20 million. The facility comprises a lettable area of circa 6,500m2 and will be fully let. […]
GCP Infrastructure notes demand for dependable and predictable income – GCP Infrastructure has announced results for the year ended 30 September 2017. The highlights are: Total shareholder return for the year of 2.6% and total return since IPO in 2010 of 97.8% NAV per ordinary share at 30 September 2017 of 110.57 pence (2016: 109.67 […]
3i Infrastructure gets bid for Elenia – In a statement released on 12 December, 3i Infrastructure said “Further to recent speculation, the board of 3i Infrastructure plc confirms that bids have been received from potential acquirers of Elenia. These bids are currently being considered by the company and the other shareholders in Elenia. The company […]
JPMorgan Chinese limiting Tencent and Alibaba exposure – JPMorgan Chinese says that, for the year ended 30 September 2017, the company delivered a return to shareholders of +36.4%. This includes the final dividend of 1.6 pence paid in February 2017. The company’s total return on net assets was +28.5%; this return was just marginally behind the MSCI […]
Baillie Gifford-favourite Alnylam completes key US filing US biotech star and Baillie Gifford stock pick Alnylam Pharmaceuticals has completed its US regulatory application for patisiran, a treatment of adults with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), putting the so-called RNA interference or “gene-silencing” therapeutic on track for approval in mid 2018. Patisiran may become Alnylam’s first […]
UK CAR-T firm Autolus provides update at ASH conference Autolus, which is a closely-watched chimeric antigen receptor T-cell therapy firm backed by three of the UK’s most prominent biotech investors, obtained an important validation of its technology recently with the publication of data on its dual targeting technology at the American Society of Hematology (ASH) conference over […]
